Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

Cancers(2023)10.3390/cancers15051402Source: DataRank Database

Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.59)OA: goldTopics (24)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Danielle Chau,Andreea Dinicu ORCID,Robert Debernardo ORCID,Ofer Reizes ORCID,Olivia G. Huffman ORCID

Live enrichment

PubMed:36900195 OpenAlex:https://openalex.org/W4321599833

VeloSano Bike to Cure, Case Comprehensive Cancer Center

Grant: NIH/NCI R21

VeloSano Bike to Cure, Case Comprehensive Cancer Center

Grant: CA262984-01

National Institutes of Health

Grant: 5R21CA262984-02

Hyperthermic Intraperitoneal Chemotherapy Mechanisms in Epithelial Ovarian Cancer

NCI NIH HHS

Grant: R21 CA262984

FWCI

4.59

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/15/5/1402/pdf?version=1678067893

publisherhttps://www.mdpi.com/2072-6694/15/5/1402/pdf?version=1678067893

publisherhttps://www.mdpi.com/2072-6694/15/5/1402/pdf

journalhttps://doi.org/10.3390/cancers15051402

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36900195

Fields of Study

Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesPolyomavirus and related diseases03 medical and health sciences0302 clinical medicine

Keywords

Hyperthermic intraperitoneal chemotherapyOvarian cancerCytoreductive surgeryMedicineChemotherapyOncologyDiseaseInternal medicineMetastasisDNA repairCancerBiologyDNAOncology and OncogenicsMedicine and PharmacologyReviewHIPEChyperthermiaimmunity

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

10.6084/m9.figshare.25734514.v1figshare

Additional file 1 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

10.6084/m9.figshare.25734514figshare

Additional file 2 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

10.6084/m9.figshare.25734695.v1figshare

Additional file 2 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis

10.6084/m9.figshare.25734695figshare